Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...
First hormone-free male birth control pill clears another milestone
While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...
WJON1d
Second Clinical Trial Begins on University of Minnesota’s Male Birth Control Pill
A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...
Managed Healthcare Executive1d
Nonopioid Pain Drug Journavx Gaining Traction With High Potential
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
Hoodline23h
Revolutionary "No-Hormones" Male Birth Control Pill Shows 99% Success, University of Minnesota's Game-Changing Study
Researchers at the University of Minnesota have developed YCT-529, a non-hormonal male birth control pill showing efficacy in ...
Soleno Therapeutics: In No Rush To Join Buying Frenzy Despite Vykat Approval
Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...
Mirage News1d
Hormone-Free Male Pill Hits Key Milestone
While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...
Minnesota research unveils breakthrough sperm blocker
MINNEAPOLIS — The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the ...
Le Lézard3d
RazorMetrics Achieves Surescripts® Clinical Direct Messaging Certification
RazorMetrics, a leading innovator in pharmacy cost containment solutions, recently achieved Surescripts® Clinical Direct Messaging certification for its medication change orders. This certification ...